MEDIFAST, INC.

(MED)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
136.79 USD   +3.61%
08/11INSIDER BUY : Medifast
MT
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/04DA Davidson Cuts Medifast's Price Target to $278 From $352, Reiterates Buy Rating
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
136.49(c) 126(c) 128.5(c) 132.02(c) 136.79(c) Last
337 725 312 872 309 440 317 631 259 123 Volume
-1.65% -7.69% +1.98% +2.74% +3.61% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 1 570 M - -
Net income 2022 131 M - -
Net cash position 2022 1,30 M - -
P/E ratio 2022 11,9x
Yield 2022 -
Sales 2023 1 665 M - -
Net income 2023 149 M - -
Net cash position 2023 12,0 M - -
P/E ratio 2023 10,2x
Yield 2023 -
Capitalization 1 499 M 1 499 M -
EV / Sales 2022 0,95x
EV / Sales 2023 0,89x
Nbr of Employees 984
Free-Float 92,3%
More Financials
Company
Medifast, Inc. sells a variety of weight loss, weight management and healthy living products all based on its own formulas under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. The Company’s product line includes approximately 95 consumable options, including, but not limited to, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft... 
Sector
Food Processing
Calendar
11/08Earnings Release
More about the company
Ratings of Medifast, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about MEDIFAST, INC.
08/11INSIDER BUY : Medifast
MT
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/04DA Davidson Cuts Medifast's Price Target to $278 From $352, Reiterates Buy Rating
MT
08/04Jefferies Downgrades Medifast to Hold From Buy; Price Target is $150
MT
08/03MEDIFAST : Q2 Earnings Snapshot
AQ
08/03MEDIFAST INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
08/03Medifast, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun..
CI
08/03MEDIFAST : Announces Second Quarter 2022 Financial Results and Updated Outlook - Form 8-K
PU
08/03TRANSCRIPT : Medifast, Inc., Q2 2022 Earnings Call, Aug 03, 2022
CI
08/03Earnings Flash (MED) MEDIFAST Posts Q2 EPS $3.87
MT
08/03Earnings Flash (MED) MEDIFAST Posts Q2 Revenue $453.3M
MT
08/03Medifast Announces Second Quarter 2022 Financial Results and Updated Outlook
PR
08/03Medifast, Inc. Revises Earnings Guidance for the Full-Year of 2022
CI
07/25Over 17,000 Registered for Flagship OPTAVIA Event Following Year of Rapid Growth
PR
07/21Medifast Announces New Scientific Advisory Board Appointments
PR
More news
News in other languages on MEDIFAST, INC.
08/11ACHAT D'INITIÉS : Medifast
08/05PUMP / DUMP #69 : Les Tops & Flops de la semaine
08/03Medifast, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le ..
08/03Earnings Flash (MED) MEDIFAST affiche un chiffre d'affaires de 453,3 millions de dollar..
08/03Medifast, Inc. révise ses prévisions de bénéfices pour l'ensemble de l'année 2022
More news
Analyst Recommendations on MEDIFAST, INC.
More recommendations
Chart MEDIFAST, INC.
Duration : Period :
Medifast, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIFAST, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 136,79 $
Average target price 214,00 $
Spread / Average Target 56,4%
EPS Revisions
Managers and Directors
Daniel R. Chard Executive Chairman & Chief Executive Officer
James P. Maloney Chief Financial Officer
Jeffrey J. Brown Lead Independent Director
Scott Schlackman Independent Director
Constance J. Hallquist Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MEDIFAST, INC.-34.68%1 499
ZHEJIANG NHU COMPANY LTD.-18.41%9 645
BY-HEALTH CO., LTD.-34.79%4 433
BALCHEM CORPORATION-20.42%4 310
THE SIMPLY GOOD FOODS COMPANY-17.80%3 430
BELLRING BRANDS, INC.-17.32%3 214